O’Dell, Sean
AstraZeneca (United Kingdom)
3 papers on CoChatORCID 0000-0002-2254-0003
Most cited papers
- Verified
Rare variant contribution to human disease in 281,104 UK Biobank exomes
Wang, Q., Dhindsa, R. S., Carss, K., Harper, A. R., Nag, A., Tachmazidou, I., Vitsios, D., Deevi, S. V. V., Mackay, A., Muthas, D., et al. (2021) · Nature
Genetic Associations and EpidemiologyGenomics and Rare Diseases
Cited by 604
- Verified
Rare variant associations with plasma protein levels in the UK Biobank
Dhindsa, R. S., Burren, O. S., Sun, B. B., Prins, B. P., Matelska, D., Wheeler, E., Mitchell, J., Oerton, E., Hristova, V. A., Smith, K. R., et al. (2023) · Nature
Genetic Associations and EpidemiologyGenomics and Rare Diseases
Cited by 193
- Verified
Double-Blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in College Students With ADHD
DuPaul, G. J., Weyandt, L. L., Rossi, J. S., Vilardo, B. A., O’Dell, S. M., Carson, K. M., Verdi, G., & Swentosky, A. (2012) · Journal of Attention Disorders
Attention Deficit Hyperactivity DisorderNeuroethics, Human Enhancement, Biomedical Innovations
Cited by 86
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free